Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis

Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis

Objective: A meta-analysis is conducted to evaluate the effectiveness and safety of bevacizumab in hereditary hemorrhagic telangiectasia (HHT) epistaxis.Method: Two researchers search PubMed, EMBASE and Web of Science databases from their inception until September 3th, 2023. The literature is read a...

Full description

Bibliographic Details
Main Authors:	Huimin Chen, Zhiping Zhang, Xiaojuan Chen, Chaoyu Wang, Mingdi Chen, Huizhao Liao, Jinru Zhu, Zhenzhen Zheng, Riken Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Pharmacology
Subjects:	bevacizumab hereditary hemorrhagic telangiectasia epistaxis treatment efficacy meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1089847/full

Similar Items

Radiofrequency for Treatment of Refractory Epistaxis in Hereditary Hemorrhagic Telangiectasia
by: Mariana Donato, et al.
Published: (2018-01-01)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
by: John M. Lee, et al.
Published: (2019-10-01)

CLINICAL APPROACH TO HEREDITARY HEMORRHAGIC TELANGIECTASIA
by: Mary Hachmeriyan, et al.
Published: (2013-11-01)

Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report
by: Meir Mei-Zahav, et al.
Published: (2017-10-01)

Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life
by: Mehmet Baysal, et al.
Published: (2019-02-01)

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
by: K. P. Thompson, et al.
Published: (2022-11-01)

Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management
by: Adrian Viteri-Noël, et al.
Published: (2022-09-01)

Telangiectasia hemorrágica hereditaria: Presentación de un caso clínico y actualización bibliográfica Hereditary hemorrhagic telangiectasia: Clinical case report and literature update
by: C Comerio, et al.
Published: (2009-09-01)

Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report
by: Erwing Castillo, et al.
Published: (2019-07-01)

Variant analysis in Chinese families with hereditary hemorrhagic telangiectasia
by: Yali Zhao, et al.
Published: (2019-09-01)

A rare case of pulmonary arterio-venous malformation with recurrent anemia: Hereditary hemorrhagic telangiectasia
by: Kamalesh Tagadur Nataraju, et al.
Published: (2015-01-01)

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
by: Meir Mei-Zahav, et al.
Published: (2020-09-01)

Case report of hereditary hemorrhagic telangiectasia with pulmonary and hepatic arteriovenous malformations
by: Tanya Aggarwal, et al.
Published: (2023-01-01)

Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study
by: Josefien Hessels, et al.
Published: (2022-09-01)

A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy
by: Panagis Galiatsatos, et al.
Published: (2022-06-01)

Surgery or No Surgery? Exploring the Dilemma of Epistaxis Management in Patients with HHT
by: Giulio Cesare Passali, et al.
Published: (2024-03-01)

Surgiflo® hemostatic matrix versus NasoPore® nasal packing following postassium titanyl phosphate laser surgery for hereditary hemorrhagic telangiectasia: A randomized controlled trial
by: Justin M. Pyne, et al.
Published: (2023-04-01)

Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of View
by: Kornelia E. C. Wirsching, et al.
Published: (2017-06-01)

Hereditary hemorrhagic telangiectasia in a sudanese patient: A case report
by: Fadi M. Toum Ahmed, et al.
Published: (2022-03-01)

Dietary iron intake and anemia: food frequency questionnaire in patients with hereditary hemorrhagic telangiectasia
by: Federica Cavalcoli, et al.
Published: (2020-10-01)

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
by: Sophie Dupuis-Girod, et al.
Published: (2020-04-01)

A Novel Variant in the ACVRL1 Gene in a Patient with Cirrhosis and Hereditary Hemorrhagic Telangiectasia
by: Mehmet Baysal, et al.
Published: (2021-08-01)

Current Status of Clinical Diagnosis and Genetic Analysis of Hereditary Hemorrhagic Telangiectasia in South Korea: Multicenter Case Series and a Systematic Review
by: Donghyun Kim, et al.
Published: (2019-09-01)

HEREDITARY HEMORRHAGIC TELANGIECTASIA
by: Messody Zagury, et al.
Published: (2015-03-01)

Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding
by: Joan D. Beckman, et al.
Published: (2020-07-01)

Treatment of hereditary haemorrhagic telangiectasia with bevacizumab – what more needs to be known?
by: Edmond Morrissey, et al.
Published: (2023-12-01)

Beneficial Effects of Remote Medical Care for Patients with Hereditary Hemorrhagic Telangiectasia during the COVID-19 Pandemic
by: Eleonora Gaetani, et al.
Published: (2021-05-01)

Telangiectasia hereditária hemorrágica: causa rara de hipertensão pulmonar? Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension?
by: Rui Providência, et al.
Published: (2010-03-01)

Future treatments for hereditary hemorrhagic telangiectasia
by: Florian Robert, et al.
Published: (2020-01-01)

Telangiectasias, recurrent epistaxis and a strong family history—a case of Osler-Weber-Rendu Syndrome in Pakistan
by: Muhammad Mustafa Arif Siddiqui, et al.
Published: (2024-03-01)

Hereditary Hemorrhagic Telangiectasia—A Case Series Experience from a Liver Transplant Center in Romania
by: Christopher Pavel, et al.
Published: (2022-11-01)

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
by: Hanny Al-Samkari, et al.
Published: (2019-11-01)

Hereditary hemorrhagic telangiectasia in a 42‐year‐old Ethiopian man presenting with severe anemia and high‐output heart failure: A case report with literature review
by: Gashaw Solela, et al.
Published: (2023-07-01)

Hereditary Hemorrhagic Telangiectasia: Success of the Osler Calendar for Documentation of Treatment and Course of Disease
by: Caroline T. Seebauer, et al.
Published: (2021-10-01)

Hereditary hemorrhagic telangiectasia and pregnancy: potential adverse events and pregnancy outcomes
by: Bari O, et al.
Published: (2017-05-01)

Case report: Diagnosis of hereditary hemorrhagic telangiectasia (Osler Weber Rendu Syndrome) in a 23-year-old male presented with anemia and thrombocytopenia and its response to bevacizumab
by: Hamza Yunus, et al.
Published: (2022-10-01)

Hereditary Hemorrhagic Telangiectasia Associating Neuropsychiatric Manifestations with a Significant Impact on Disease Management—Case Report and Literature Review
by: Fabiola Sârbu, et al.
Published: (2022-07-01)

Enfermedad de Rendú-Osler-Weber: a propósito de 5 casos con epístaxis recurrente Rendú-Osler-Weber disease: apropos of 5 cases with recurrent epistaxis
by: Tahamara Alcalá-Villalón, et al.
Published: (2012-09-01)

Hereditary hemorrhagic telangiectasia associated with inherited thrombophilia
by: Roganović Branka, et al.
Published: (2017-01-01)

Gender differences in hereditary hemorrhagic telangiectasia severity
by: J. M. Mora-Luján, et al.
Published: (2020-03-01)